Safety Reporting
Current section refers to the item 4.11 Safety Reporting of the INTEGRATED ADDENDUM TO ICH E6(R1): GUIDELINE FOR GOOD CLINICAL PRACTICE E6(R2). It provides an overview of requirements for reporting of Serious Adverse Events occurring during a clinical trial.
4.11.1 All serious adverse events (SAEs) should be reported immediately to the sponsor except for those SAEs that the protocol or other document (e.g., Investigator's Brochure) identifies as not needing immediate reporting. The immediate reports should be followed promptly by detailed, written reports.
The immediate and follow-up reports should identify subjects by unique code numbers assigned to the trial subjects rather than by the subjects' names, personal identification numbers, and/or addresses.
The investigator should also comply with the applicable regulatory requirement(s) related to the reporting of unexpected serious adverse drug reactions to the regulatory authority(ies) and the IRB/IEC.
4.11.2 Adverse events and/or laboratory abnormalities identified in the protocol as critical to safety evaluations should be reported to the sponsor according to the reporting requirements and within the time periods specified by the sponsor in the protocol.
4.11.3 For reported deaths, the investigator should supply the sponsor and the IRB/IEC with any additional requested information (e.g., autopsy reports and terminal medical reports).
Clinical Research News
Prossimi studi clinici
-
Zheng LiNon ancora reclutamentoFragilità cognitiva
-
Techpool Bio-Pharma Co., Ltd.Non ancora reclutamento
-
Istanbul University - CerrahpasaReclutamentoParalisi cerebraleTurchia (Türkiye)
-
Project Skin MDNon ancora reclutamento
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Non ancora reclutamentoIctus ischemico acuto AIS
-
Hospital Universitario La PazNon ancora reclutamentoOstruzione nasale | Bronchiolite | Infezioni acute del tratto respiratorio superioreSpagna
-
E-DA HospitalNational Cheng Kung University; Metal Industries Research & Development Centre...ReclutamentoApnea ostruttiva del sonnoTaiwan
-
Assistance Publique - Hôpitaux de ParisNon ancora reclutamentoComplicazione dell'ossigenazione extracorporea della membrana | ECMO Cannula InfectionFrancia
-
Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd.ReclutamentoCancro al seno | Tumore gastrico | Cancro ovarico | Tumori solidi avanzati | Altri tumori solidiCina
-
Gustave Roussy, Cancer Campus, Grand ParisNon ancora reclutamentoAdult Carriers of a Pathogenic or Probably Pathogenic (Class 4 and 5) Germline Variation in the TP53 GeneFrancia
-
Assistance Publique - Hôpitaux de ParisReclutamento
-
University GhentNon ancora reclutamentoDolore postoperatorio, acuto | Pulpite irreversibile (mal di denti) | Pulp Necrosis, Apical PeriodontitisBelgio
Clinical Research Jobs
-
Italy - Milan
-
United States - Shrewsbury
-
United Kingdom - Leeds
-
India - Kochi
-
United States - Massachusetts - Boston
-
India - Bengaluru
-
United States - North Carolina - Morrisville
-
China